gallein,
Gallein,
2103-64-2,
Alizarin violet,
Pyrogallolphthalein,
3',4',5',6'-Tetrahydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one,
Mordant violet 25,
C.I. Mordant Violet 25,
4,5-Dihydroxyfluorescein,
Callein,
Alizarine violet,
C.I. 45445,
UNII-8L0084U2QR,
Fluorescein, 4',5'-dihydroxy-,
NSC8668,
8L0084U2QR,
NSC 8668,
NSC56445,
3',4',5',6'-Tetrahydroxyfluoran,
Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',4',5',6'-tetrahydroxy-,
NSC 56445,
NSC622478,
NSC 622478,
Fluoran, 3',4',5',6'-tetrahydroxy-,
Fluorescein,5'-dihydroxy-,
W-107581,
Fluoran,4',5',6'-tetrahydroxy-,
3',4',5',6'-Tetrahydroxyspiro(isobenzofuran-1(3H),9'-(9H)xanthene)-3-one,
Spiro[isobenzofuran-1(3H), 3',4',5',6'-tetrahydroxy-,
Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 3',4',5',6'-tetrahydroxy-,
Gallein (8CI),
AC1L2KAS,
AC1Q6PCI,
SCHEMBL334144,
DTXSID5062180,
CHEBI:88294,
KS-00000YFB,
PHLYOKFVXIVOJC-UHFFFAOYSA-N,
NSC-8668,
ZINC4416138,
EINECS 218-272-6,
BS0301,
MFCD00041839,
NSC-56445,
AKOS015903075,
ACM2103642,
NSC-622478,
AJ-51074,
AN-19840,
AI3-63042,
AX8131803,
A0601,
B7271,
FT-0603588,
ST24028148,
I14-18554,
3',4',5',6'-tetrahydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one,
3',4',5',6'-tetrahydroxyspiro[isobenzofuran-3,9'-xanthene]-1-one,
3',4',5',6'-tetrahydroxy-3H-spiro[2-benzofuran-1,9'-xanthen]-3-one,
3',4',5',6'-Tetrahydroxyspiro[isobenzofuran-1(3H),9'-(9H)xanthen]-3-one,
Spiro(isobenzofuran-1(3),9'-(9H)xanthen)-3-one, 3',4',5',6'-tetrahydroxy-,
52413-17-9,
Pyrogallolphthalein: 12,13,14,15-Tetrahydroxyspiro[3-hydroisobenzofuran-3,9'-xanthene]-1-one,
Pyrogallol phthalein,
D0XN2L,
CID73685,
AR-1J1139,
NSC158916,
M-119,
G protein beta gamma subunit inhibitors (heart failure),
G protein beta gamma subunit inhibitors (heart failure), Califia/URMC,
5340-14-7,